MEDICA and COMPAMED 2022 Planning Enters Next Stage, Exhibitors Can Still Register
|
By LabMedica International staff writers Posted on 21 Jul 2022 |

The planning for the world’s leading medical trade fair MEDICA 2022 as well as for COMPAMED 2022, the No. 1 trade fair for suppliers of the medical technology industry, organized by Messe Düsseldorf (Düsseldorf, Germany), has entered the next stage. The current number of exhibitor registrations indicates that participation will surpass last year’s results (MEDICA 2021: 3,033; COMPAMED 2021: 490). Exhibitors can still register online for all segments at MEDICA and COMPAMED which will take place concurrently from November 14 – 17, 2022 at the fairgrounds in Düsseldorf, Germany.
In their globally unique combination, MEDICA 2022 and COMPAMED 2022 will again reflect the entire medical technology value and process chains and present a comprehensive range of medical products, devices and instruments. In 2021, 46,000 trade visitors took part in both events (73% international participation). The focus segments of the MEDICA trade fair are: Laboratory Technology and Diagnostics, Medical Technology and Electromedicine (Imaging and Diagnostics/ Medical Equipment and Devices), Consumer Goods and Consumables, Physiotherapy and Orthopedic Technology, and IT Systems and IT Solutions.
For years, startups from all countries have always participated in MEDICA and COMPAMED in large numbers, both with their own stands and as part of joint stands. The MEDICA START-UP PARK offers an attractive opportunity for participation, especially for first-time exhibitors. In addition to booth presentations, start-ups and scale-ups (companies in the next stage of development) will again provide interesting insights into their current projects in various pitch and presentation formats. For example, the MEDICA DISRUPT sessions, the 11th MEDICA START-UP COMPETITION and the 14th Healthcare Innovation World Cup will all be program highlights at the MEDICA CONNECTED HEALTHCARE FORUM. Overall, about 120 speakers and more than 100 startups will be on hand to discuss digital innovations for mobile and connected healthcare of the future.
Further forums integrated into the individual thematic segments of the trade fair provide a connection to the product innovations and best practices of their application in everyday medical practice. In addition to the MEDICA CONNECTED HEALTHCARE FORUM, these include the MEDICA HEALTH IT FORUM, the MEDICA TECH FORUM, the MEDICA LABMED FORUM and the MEDICA ECON FORUM. The MEDICA conference program also provides a content link to the trend topics of the market and the trade fair. An example is the 45th German Hospital Day, a leading event for the top management of German hospitals, which this year will be held face-to-face again. Two other (English language) conferences will address a mainly international audience: the Conference on Disaster and Military Medicine DiMiMED, and the MEDICA MEDICINE + SPORTS CONFERENCE for the international professional sports medicine and sports science sector.
In order to keep up to date with trends in the preliminary development or manufacturing stages of the medical technology industry, COMPAMED is and remains the must-attend event. This is where supplier companies present a wealth of high-tech and service solutions. Components, microsystems technology, materials processing and coatings, additive manufacturing/ 3D printing, manufacturing technology and machines, packaging and services are key segments that are also reflected by the programs of the two integrated specialist forums: The COMPAMED HIGH-TECH FORUM organized by the IVAM Microtechnology Association and the COMPAMED SUPPLIERS FORUM managed by the trade publication Devicemed. Demand for micro components and processes in the context of digitization and patient-centered diagnostics remains strong since they key to ultra-precise manufacturing and the foundation for lightweight, portable and interconnected devices.
“The medical technology industry right now needs MEDICA and COMPAMED as strong platforms for international exchange, cooperation and business. Because the market is in flux. In certain areas, the pandemic is causing increased demand, for example in point-of-care diagnostics. In addition, companies are seeing an increasing necessity to work jointly with their supply and manufacturing partners to ensure delivery capacity during a time of sharply rising prices and scarce components,” said Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf. “International networking also helps to open up new markets. You can broaden the base for your own business, while alleviating the effects of obstacles, uncertainties or even sanctions that may apply to certain national markets.”
Related Links:
Messe Düsseldorf
Latest Industry News
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







